Skip to Main Content

News

Results: 37 Articles found.
  • Possible drug induced retinal maculopathy secondary to long-term use of pentosan polysulfate sodium (Elmiron)

    Aug 11, 2020 11:10 AM

    Pentosan polysulfate sodium (PPS) was approved by the Food and Drug Administration (FDA) in 1985 for the relief of bladder pain or discomfort associated with Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS). Currently, it is the only FDA approved oral agent for the treatment of IC/PBS. Due to the limited availability of alternative treatments for IC/PBS, many patients may rely on long-term continuation of this drug for relief of symptoms.

    Read More
  • Menefee

    AUGS Diversity and Inclusion Task Force Call for Volunteers

    Jun 07, 2020 03:00 PM

    After my President’s Perspective on racial equity and diversity, AUGS received numerous letters expressing thoughts on our sub-specialty history, member concerns, and the health care disparities related both to our patients and research within our field. I was able to listen and talk with many members and this was a powerful experience for me personally and confirmed the need for all of us to make sure that AUGS is a welcoming society for all our members.

    Read More
  • Menefee

    Call for Volunteers and Board Nominations

    Jun 02, 2020 12:50 PM

    We are making our annual Call for Volunteers and Board Nominations to move our Society forward. Now more than ever we need our members to engage and participate in AUGS. It is in large part because of the numerous committed volunteers over the years that AUGS and our specialty are where we are today.​

    Read More
  • Joint Statement on Re-introduction of Hospital and Office-based Procedures in the COVID-19 Climate for the Practicing Urogynecologist and Gynecologist

    Apr 29, 2020 04:49 PM

    Traditionally, surgical procedure prioritization depends on illness acuity and resource availability after shared decision making with patients. During an emergency such as the COVID-19 pandemic, decisions must take into consideration new influences on the safety of benign gynecologic procedures. Prioritization of patients must be fluid as the pandemic waxes and wanes and is likely different in the peaks than the troughs of infection incidence.

    Download Document
  • Menefee

    PFD Week 2020 Vancouver

    Feb 20, 2020 01:16 PM

    As many of you are preparing your abstracts for PFD Week 2020, I wanted to update everyone on a few changes to the annual meeting structure. In an effort to be responsive to attendee and member feedback on the annual meeting, the Board created a task force to take a closer look at how we could retain the meeting’s excellent reputation, while allowing for new ideas and concepts to ensure the meeting continues to be our flagship event each year.

    Read More
  • Menefee

    Announcing the AUGS Innovation Lectureship Award

    Jan 06, 2020 03:53 PM

    Wishing everyone a Happy New Year and looking forward to a great 2020 for our society. It is with excitement that I announce on behalf of the AUGS Board the inaugural AUGS Innovation Lectureship at PFD Week 2020 in Vancouver. Looking toward our future, this award is intended to honor members of the society and national/global community at large who have made major innovative contributions to the field of female pelvic medicine and reconstructive surgery.

    Read More
  • Menefee

    Looking Towards 2020

    It is with great pleasure that I write my first President’s Perspective. First, I want to thank everyone for contributing to the successful AUGS/IUGA Joint Scientific Meeting in Nashville. This meeting was our largest to date, with 2,237 in attendance.

    Read More
  • Cundiff__5b1_5d2018

    State of the Society

    Oct 17, 2019 10:32 AM

    As I complete my Presidency of AUGS, I would like to bring to you a summary of the State of the Society. 2019 has been a busy year with many developments that impact our specialty but are outside of our direct control.

    Read More
  • Cundiff__5b1_5d2018

    AUGS Creates a Patient Advisory Group

    Aug 02, 2019 01:18 PM

    The American Urogynecologic Society was founded to serve the needs of medical professionals serving women who suffer from pelvic floor disorders. Patients have always been at the center of AUGS' mission, but have not been directly involved in the conversation.

    Read More
  • Cundiff__5b1_5d2018

    AUGS Code of Conduct for Expert Witnesses

    Jun 06, 2019 10:50 AM

    In recent months many members of AUGS have been frustrated by misinformation related to surgical technologies and materials that creates fear and anxiety in our patients. Media reports are often superficial and polarizing. For example, coverage of FDA decisions often fails to distinguish between transvaginal mesh for prolapse, and other forms of pelvic mesh (such as slings or sacrocolpopexy mesh). Even more alarming are those who employ misinformation and fear to seek personal profit.

    Read More
  • Cundiff__5b1_5d2018

    Call for Volunteers and Board Nominations

    May 22, 2019 10:57 AM

    Have you ever thought about volunteering to help AUGS? It is that time of year for our annual Call for Volunteers and Board Nominations, so maybe you should.

    Read More
  • Cundiff__5b1_5d2018

    Update on FDA Announcement on Transvaginal Mesh for Prolapse

    I write today to update my last Presidential Message from April 18, 2019 on the April 16th FDA Announcement ordering both manufacturers of the three surgical mesh products for transvaginal repair of prolapse to stop selling and distributing their products in the U.S.

    Read More
  • Cundiff__5b1_5d2018

    FDA Announcement on Transvaginal Mesh for Prolapse

    Apr 18, 2019 10:40 AM

    AUGS received notice from the FDA on Tuesday, April 16, of the simultaneous public notice, “FDA Takes Action to Protect Women’s Health; Orders Manufacturers of Surgical Mesh Intended for Transvaginal Repair of Pelvic Organ Prolapse to Stop Selling All Devices”. The notice orders all manufacturers of surgical mesh products for transvaginal repair of prolapse to stop selling and distributing their products in the U.S. immediately.

    Read More
  • Cundiff__5b1_5d2018

    AUGS to Testify at FDA Advisory Committee Meeting

    On February 12, 2019, the FDA plans to convene an Advisory Committee Meeting to share the available evidence and seek expert opinion on the evaluation of the benefits and risks of trans-vaginal mesh devices for anterior pelvic organ prolapse. This will provide an opportunity for the FDA to hear directly from the public, including patients, about their experiences, and consider additional regulatory actions.

    Read More
  • Cundiff__5b1_5d2018

    President’s Perspective: Statement on Gender Identification

    Oct 31, 2018 12:49 PM

    The U.S. Administration recently notified the media that they are considering the adoption of a narrow definition of gender. The new definition limits gender to male or female, based entirely on an assessment of genitalia at birth.

    Read More
  • Rardin_Charles_2018

    President’s Perspective: Meeting Code of Conduct for AUGS Members

    Sep 11, 2018 01:00 AM

    PFD Week is just around the corner, and Chicago in the early autumn is beckoning! The Program Committee has put together an outstanding lineup of all of the science, updates, addresses, and networking that you have come to expect from our annual meeting. Bring your energy, curiosity, enthusiasm, and an open mind to this exchange of expertise and ideas. Bring your concerns and your solutions to the many AUGS Volunteer meetings and activities that go on around the meeting.

    Read More
  • Rardin_Charles_2018

    Energy-Based Devices and Vaginal Rejuvenation

    Aug 08, 2018 04:16 PM

    As you may already know, the FDA released a Safety Communication on July 30 which provided a public warning regarding the use of “Energy-Based Devices to Perform Vaginal 'Rejuvenation' or Vaginal Cosmetic Procedures.” It was very clear in addressing this warning to patients considering undergoing the treatments, and to health care providers who offer them.

    Read More
  • Rardin_Charles_2018

    The Role of Volunteers in AUGS

    May 22, 2018 12:47 PM

    Have you ever logged on to the AUGS website and really looked around at all the things that AUGS is doing? It is a truly impressive array of activities and services; I hope you will take a moment to peruse the site and learn about some project, committee or member benefit of which you had not previously been aware. And what makes all of that happen? It’s our volunteers.

    Read More
  • Rardin_Charles_2018

    AUGS is Neither Pro-Mesh; nor Anti-Mesh - AUGS is Pro-science and Science and Evidence Must Lead the Way

    May 16, 2018 04:46 PM

    AUGS advocates for evidence-based options that enhance the choices available to members and their patients who suffer with pelvic floor disorders.

    Read More
  • Rardin_Charles_2018

    Mesh and the Court of Public Opinion

    May 11, 2018 10:54 AM

    AUGS recently became aware that, on Sunday, May 13th, “60 Minutes” will be airing a segment on mesh injuries. We know that some of the content will include interviews with patients; beyond that, we don’t know what to expect. We should be prepared, however, for a public reaction, and another layer of anxiety that our patients bring with them into our offices.

    Read More
  • Rardin1

    Developing the Role of Advanced Practice Providers in Your Urogynecology Practice

    I am taking this opportunity to bring your attention to the upcoming release of a new AUGS document, entitled, “A Training Guide - Core Competencies for the Advance Practice Provider Entering Urogynecology.” This document has been developed to assist practices in the hiring and training of APPs for Urogynecology-focused offices.

    Read More
  • Rardin

    President's Perspective: The Conversation Continues

    Oct 13, 2017 11:52 AM

    PFD Week, the highlight of the AUGS calendar, has now wrapped up, and Providence seems a little smaller without you all here! It was an amazingly rich program, with record participation in workshops and courses; as always, the level of the science presented here establishes the standard in FPMRS. We hosted leadership from IUGA and SUFU, as well as leaders from South American societies and an Ethiopian surgical network; our program - and our meeting - were the richer for their presence.

    Read More
  • ZYCZYNSKI_HALINA_MD_OBG_20131121email

    We Will Choose Whom We Honor

    Sep 15, 2017 02:19 PM

    Within the past 24 hours, a petition has been directed to the AUGS board regarding removing the J. Marion Sims name from one of our keynote addresses. Though my intent was to address this topic in my State of the Society address to all members, I now think it best to reassure you that the Board has not been ignoring this issue.

    Read More
  • presidents-perspective

    AUGS Educational Programming Expands in 2018 - Something for Everyone

    Aug 18, 2017 04:55 PM

    For over 35 years AUGS has produced the leading scientific meeting in the FPMRS field. Our Annual Scientific Meeting brings together successful and developing clinicians, researchers and scientists to exchange ideas, report on innovations and reconnect with colleagues. Thanks to the hard work and creativity of Cheryl Iglesias and the program committee you will find the content of PFD Week 2017 to be both relevant and provocative.

    Read More
  • presidents-perspective

    Call for Board Nominations

    Jun 30, 2017 02:57 PM

    It is an honor to serve as the Society’s 38th President and to work with members of the Board who are dedicated to ensuring the growth and prosperity of AUGS for today and the future. Board service is truly a rewarding experience and one that I hope many of you will consider at some point in your career. If you are interested in running for the AUGS Board of Directors or know a colleague that would be an asset to the Board, now is the time to submit that nomination.

    Read More
  • presidents-perspective

    Welcome to the brand-new AUGS website!

    Apr 24, 2017 12:58 PM

    Today, AUGS is excited to launch our new improved websites for AUGS, the PFD Research Foundation, PFD Week and Voices for PFD. The launch of these new websites culminates a yearlong undertaking of research and implementation.

    Read More
  • presidents-perspective

    Still Time to Protect Your Practice from a 4% Cut in Medicare Payments

    Feb 01, 2017 01:16 PM

    This year marks the beginning of a new physician reimbursement system that will impact many AUGS members. I write to inform you about two AUGS initiatives aimed at providing our members the resources they need to meet the CMS reporting requirements for full compensation in 2019. The AUGS Board has approved the addition of a new Practice Management Course to be held on March 25 in San Antonio, TX.​

    Read More
  • presidents-perspective

    FDA Issues Final Reclassification Order for Instrumentation for Use with Urogynecologic Mesh

    Jan 06, 2017 01:21 PM

    Today, the FDA issued a final reclassification order regarding Surgical Instrumentation for Use with Urogynecologic Surgical Mesh from Class I to Class II. Examples of the surgical instruments covered by the order include needle passers and trocars, needle guides, fixation tools, and tissue anchors for procedures including transvaginal POP repair, sacral colpopexy (transabdominal POP repair) and treatment of female SUI.

    Read More
Results: 37 Articles found.
 
Close